• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Mativ Announces Second Quarter 2025 Results

    8/6/25 4:30:00 PM ET
    $MATV
    Paper
    Basic Materials
    Get the next $MATV alert in real time by email

    Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE:MATV) reported earnings results for the three months ended June 30, 2025.

    Adjusted measures are reconciled to GAAP at the end of this release. Financial comparisons are versus the prior year period unless stated otherwise. Figures may not sum to total due to rounding.

    Mativ Second Quarter 2025 Highlights

    • Sales of $525.4 million increased 0.3% year over year, and 2.6% on an organic basis
    • GAAP loss was $9.5 million, GAAP EPS was $(0.18)
    • Adjusted EBITDA was $67.2 million, Adjusted income was $18.5 million, and Adjusted EPS was $0.33, (see non-GAAP reconciliations). Adjusted EBITDA was up 1% versus the prior year period, as lower SG&A expenses across the company, higher organic volume in SAS and favorable cost mix in FAM were partially offset by higher manufacturing and distribution costs, and unfavorable net selling price versus input cost performance.
    • Second-highest cash flow quarter since the merger, with cash from operating activities of $57.6 million, and free cash flow of $48.9 million, up 25% and 33% versus the prior year period, respectively.

    Management Commentary

    "We delivered solid results within both FAM and SAS segments and across the enterprise," said Shruti Singhal, Mativ President and CEO. "Mativ's second quarter results reflect a year over year growth in adjusted EBITDA as well as a significant sequential quarterly increase in both adjusted EBITDA and free cash flow. Organic volume increases in our SAS segment together with disciplined cost and expense control led the year-over-year improvement in adjusted EBITDA, and our focus on cash flow and working capital optimization produced our second-highest cash flow quarter as Mativ.

    We continue to operate at an increased pace of execution, and our strong performance in Q2 reflects the corresponding results. I want to thank our capable and engaged global Mativ team, who remains relentlessly focused on enhanced commercial delivery and ensuring Mativ's agility in this challenging tariff and macro-economic environment. Our strategic portfolio review is underway evaluating opportunities to supplement the work we are doing to strengthen our balance sheet and reduce our leverage profile, and our results to date have galvanized our team's focus on generating strong year-over-year adjusted EBITDA and free cash flow improvement for the remainder of the year."

    Mativ Second Quarter 2025 Financial Results

    Filtration & Advanced Materials (FAM)

    Three Months Ended June 30,

    (in millions; unaudited)

     

    2025

     

     

     

    2024

     

     

    Change

     

    2025

     

    2024

    Net Sales

    $

    204.4

     

    $

    206.4

     

    $

    (2.0

    )

     

     

     

     

    GAAP Operating Profit & Margin %

    $

    22.6

     

     

    $

    25.2

     

     

    $

    (2.6

    )

     

    11.1

    %

     

    12.2

    %

    Adjusted EBITDA & Margin %

    $

    40.6

     

     

    $

    42.3

     

     

    $

    (1.7

    )

     

    19.9

    %

     

    20.5

    %

    Filtration & Advanced Materials (FAM) segment sales, comprised primarily of filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, were $204.4 million, down 1.0% versus the prior year period, reflecting lower selling prices, lower volume/mix, partially offset by favorable currency translation.

    GAAP Operating Profit in 2025 included $2.2 million of restructuring expenses, compared to $1.2 million in 2024. Adjusted EBITDA (see non-GAAP reconciliations) decreased 4.0% versus prior year as lower SG&A expenses and favorable cost mix were more than offset by higher manufacturing and distribution costs, and unfavorable net selling price versus input cost performance.

    Sustainable & Adhesive Solutions (SAS)

    Three Months Ended June 30,

    (in millions; unaudited)

     

    2025

     

     

     

    2024

     

     

    Change

     

    2025

     

    2024

    Net Sales

    $

    321.0

     

    $

    317.4

     

    $

    3.6

     

     

     

     

     

    GAAP Operating Profit & Margin %

    $

    24.8

     

     

    $

    15.6

     

     

    $

    9.2

     

     

    7.7

    %

     

    4.9

    %

    Adjusted EBITDA & Margin %

    $

    45.3

     

     

    $

    46.2

     

     

    $

    (0.9

    )

     

    14.1

    %

     

    14.6

    %

    Sustainable & Adhesive Solutions (SAS) segment sales, comprised primarily of tapes, labels, liners, specialty paper, packaging and healthcare solutions, of $321.0 million were up 5.0% on an organic basis, and up 1.1%, on a reported basis, versus the prior year period. Higher organic volume, higher selling prices, and favorable currency translation were partially offset by sales associated with closed and divested plants.

    GAAP Operating Profit in 2025 included $0.2 million in restructuring expenses, compared to $10.1 million of restructuring and other impairment expenses in 2024. Adjusted EBITDA (see non-GAAP reconciliations) decreased 1.9% compared to the prior year period, as lower SG&A expenses, and higher volume excluding the impact from closed and divested plants were more than offset by higher manufacturing and distribution costs.

    Unallocated

    Three Months Ended June 30,

    (in millions; unaudited)

     

    2025

     

     

     

    2024

     

     

    Change

     

    2025

     

    2024

    GAAP Operating Expense & % of Sales

    $

    (27.3

    )

     

    $

    (30.3

    )

     

    $

    3.0

     

    (5.2

    )%

     

    (5.8

    )%

    Adjusted EBITDA & % of Sales

    $

    (18.7

    )

     

    $

    (21.9

    )

     

    $

    3.2

     

     

    (3.6

    )%

     

    (4.2

    )%

    GAAP operating expenses in 2025 included $1.9 million in organizational realignment costs.

    Adjusted unallocated expenses (EBITDA) (see non-GAAP reconciliations) decreased $3.2 million versus prior year primarily driven by lower SG&A expenses.

    Interest expense was $18.6 million versus $18.4 million in the prior year period.

    Other income (expense), net was $1.5 million and decreased $2.6 million compared with the prior year primarily driven by gains on asset sales and foreign currency gains.

    Tax was a 416.7% expense for the three months ended June 30, 2025, driven by a change in valuation allowances and one-time adjustments.

    Non-GAAP Adjustments reflect items included in GAAP operating profit, income, and EPS, but excluded from adjusted results (see non-GAAP reconciliation tables for additional details). The most significant adjustment to the second quarter 2025 results were:

    • $0.31 per share of purchase accounting expenses (purchase accounting expenses reflect primarily ongoing non-cash intangible asset amortizations associated with mergers and acquisitions)
    • $0.09 per share due to restructuring expenses
    • $0.08 per share due to organizational realignment costs

    Cash Flow & Debt

    Year-to-date 2025 cash provided by operating activities was $41.7 million. Capital spending and software costs totaled $22.6 million. Working capital was a $11.1 million use of cash due to the impact of an increase in accounts receivable, partially offset by a decrease in inventories and increase in accounts payable.

    Total debt was $1,090.6 million as of June 30, 2025 and Cash and cash equivalents was $95.6 million resulting in net debt of $995.0 million. Total liquidity was approximately $453 million, consisting of $96 million of Cash and cash equivalents and $357 million of revolver availability. The Company's debt matures on a staggered basis between 2027 and 2029.

    Dividend & Share Repurchases

    On August 6, 2025 the Company announced its next quarterly cash dividend of $0.10 per share payable on September 26, 2025 to stockholders of record as of August 29, 2025.

    During the second quarter, the Company did not repurchase shares.

    Conference Call

    Mativ will hold a conference call to review second quarter 2025 results with investors and analysts at 8:30 a.m. Eastern time on Thursday, August 7, 2025. The earnings conference call will be simultaneously broadcast over the Internet at http://ir.mativ.com. To listen to the call, please go to the Company's website at least 15 minutes prior to the call to register and to download and install any necessary audio software. For those unable to listen to the live broadcast, a replay will be available on the Company's website shortly after the call.

    About Mativ

    Mativ Holdings, Inc. is a global leader in specialty materials, solving our customers' most complex challenges by engineering bold, innovative solutions that connect, protect and purify our world. Headquartered in Alpharetta, Georgia, we manufacture on three continents and generate sales in over 80 countries through our family of business-to-business and consumer product brands. The company's two operating segments, Filtration & Advanced Materials and Sustainable & Adhesive Solutions, target premium applications across diversified and growing categories. Our broad portfolio of technologies combines polymers, fibers and resins to optimize the performance of our customers' products across multiple stages of the value chain. Our leading positions are a testament to our best-in-class global manufacturing, supply chain and materials science capabilities. We drive innovation and enhance performance, finding potential in the impossible.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by the Act and other legal protections. Forward-looking statements include, without limitation, those regarding the incurrence of additional debt and expected maturities of the Company's debt obligations, the adequacy of our sources of liquidity and capital, acquisition integration and growth prospects (including international growth), the cost and timing of our restructuring actions, the impact of ongoing litigation matters and environmental claims, the amount of capital spending and/or common stock repurchases, future cash flows, purchase accounting impacts, impacts and timing of our ongoing operational excellence and other cost-reduction and cost-optimization initiatives, profitability, and cash flow, the expected benefits and accretion of the Neenah merger and Scapa acquisition and integration, whether the strategic benefits of the EP Divestiture can be achieved and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words.

    These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company's business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ materially from our expectations as of the date of this release. These risks include, among other things, the following factors:

    • Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies;
    • Risks associated with acquisitions, dispositions, strategic transactions and global asset realignment initiatives of Mativ;
    • Adverse changes in our end-market sectors impacting key customers;
    • Changes in the source and intensity of competition in our commercial end-markets;
    • Adverse changes in sales or production volumes, pricing and/or manufacturing costs;
    • Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods;
    • Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely;
    • Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin, fiber, and chemical suppliers, to supply materials as needed to maintain our product plans and cost structure;
    • Increases in operating costs due to inflation and continuing increases in the inflation rate or otherwise, such as labor expense, compensation and benefits costs;
    • Our ability to attract and retain key personnel, labor shortages, labor strikes, stoppages or other disruptions;
    • Changes in general economic, financial and credit conditions in the U.S., Europe, China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro) and on interest rates;
    • A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty;
    • Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions;
    • Changes in tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities;
    • Uncertainty as to the long-term value of the common stock of Mativ;
    • Changes in employment, wage and hour laws and regulations in the U.S. and elsewhere, including unionization rules and regulations by the National Labor Relations Board, equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws;
    • The impact of tariffs, the imposition of any future additional tariffs and other trade barriers, the effects of retaliatory trade measures, and the impact of tariff uncertainty on macroeconomic conditions;
    • Existing and future governmental regulation and the enforcement thereof that may materially restrict or adversely affect how we conduct business and our financial results;
    • Weather conditions, including potential impacts, if any, from climate change, known and unknown, and natural disasters or unusual weather events;
    • International conflicts and disputes, such as the ongoing conflict between Russia and Ukraine, the war between Israel and Hamas and the broader regional conflict in the Middle East, which restrict our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions;
    • Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations;
    • Risks associated with pandemics and other public health emergencies;
    • The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs;
    • Increased scrutiny from stakeholders related to environmental, social and governance ("ESG") matters, as well as our ability to achieve our broader ESG goals and objectives;
    • Costs and timing of implementation of any upgrades or changes to our information technology systems;
    • Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information;
    • Information technology system failures, data security breaches, network disruptions, and cybersecurity events; and
    • Other factors described elsewhere in this document and from time to time in documents that we file with the SEC.

    All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and Mativ undertakes no obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise. For a more detailed discussion of these factors, also see the information under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Mativ's most recent annual report on Form 10-K for the year ended December 31, 2024 and any material updates to these factors contained in any of Mativ's future filings with the SEC. The discussion of these risks is specifically incorporated by reference into this release. The financial results reported in this release are unaudited.

    Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data. The financial results reported in this release are unaudited.

    Non-GAAP Financial Measures

    Certain financial measures and comments contained in this press release exclude restructuring and impairment expenses, certain purchase accounting adjustments related to prior acquisitions, organizational realignment and integration costs, divestiture costs, interest expense, stock compensation expense, inventory step-up expense, the effect of income tax provisions and other tax impacts, capital spending, capitalized software costs, cloud-based software costs and depreciation and amortization. This press release also provides certain information regarding the Company's financial results excluding currency impacts. This information estimates the impact of changes in foreign currency rates on the translation of the Company's current financial results as compared to the applicable comparable period and is derived by translating the current local currency results into U.S. Dollars based upon the foreign currency exchange rates for the applicable comparable period. Financial measures which exclude or include these items have not been determined in accordance with accounting principles generally accepted in the United States (GAAP) and are therefore "non-GAAP" financial measures. Reconciliations of these non-GAAP financial measures to the most closely analogous measure determined in accordance with GAAP are included in the financial schedules attached to this release.

    The Company believes that the presentation of non-GAAP financial measures in addition to the related GAAP measures provides investors with greater transparency on the information used by the Company's management in its financial and operational decision-making. Management also believes that the non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operational performance in the same way that management evaluates the Company's financial performance. Management believes that providing this information enables investors to better understand the Company's operating performance and financial condition. These non-GAAP financial measures are not calculated or presented in accordance with, and are not intended to be considered in isolation or as alternatives or substitutes for, or superior to, financial measures prepared and presented in accordance with GAAP, and should be read only in conjunction with the Company's financial measures prepared and presented in accordance with GAAP. The non-GAAP financial measures used in this release may be different from the measures used by other companies.

     

    MATIV HOLDINGS, INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF INCOME (LOSS)

    (in millions, except per share amounts)

    (Unaudited)

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

    2025

     

     

     

    2024

     

     

    % Change

     

     

    2025

     

     

     

    2024

     

     

    % Change

    Net sales

    $

    525.4

     

     

    $

    523.8

     

     

    0.3

    %

     

    $

    1,010.2

     

     

    $

    1,024.0

     

     

    (1.3

    )%

    Cost of products sold

     

    421.7

     

     

     

    414.9

     

     

    1.6

    %

     

     

    833.9

     

     

     

    831.1

     

     

    0.3

    %

    Gross profit

     

    103.7

     

     

     

    108.9

     

     

    (4.8

    )%

     

     

    176.3

     

     

     

    192.9

     

     

    (8.6

    )%

     

     

     

     

     

     

     

     

     

     

     

     

    Selling and general expense

     

    57.2

     

     

     

    65.1

     

     

    (12.1

    )%

     

     

    120.5

     

     

     

    126.7

     

     

    (4.9

    )%

    Research and development expense

     

    6.7

     

     

     

    5.8

     

     

    15.5

    %

     

     

    13.0

     

     

     

    11.8

     

     

    10.2

    %

    Intangible asset amortization expense

     

    15.9

     

     

     

    15.7

     

     

    1.3

    %

     

     

    31.3

     

     

     

    31.5

     

     

    (0.6

    )%

    Total nonmanufacturing expenses

     

    79.8

     

     

     

    86.6

     

     

    (7.9

    )%

     

     

    164.8

     

     

     

    170.0

     

     

    (3.1

    )%

     

     

     

     

     

     

     

     

     

     

     

     

    Goodwill impairment expense

     

    —

     

     

     

    —

     

     

    N.M.

     

     

    411.9

     

     

     

    —

     

     

    N.M.

    Restructuring and other impairment expense

     

    3.8

     

     

     

    11.8

     

     

    (67.8

    )%

     

     

    10.1

     

     

     

    26.2

     

     

    (61.5

    )%

    Operating profit (loss)

     

    20.1

     

     

     

    10.5

     

     

    91.4

    %

     

     

    (410.5

    )

     

     

    (3.3

    )

     

    N.M.

    Interest expense

     

    18.6

     

     

     

    18.4

     

     

    1.1

    %

     

     

    36.4

     

     

     

    36.7

     

     

    (0.8

    )%

    Other income (expense), net

     

    1.5

     

     

     

    (1.1

    )

     

    N.M.

     

     

    (0.3

    )

     

     

    0.6

     

     

    N.M.

    Income (loss) before income taxes

     

    3.0

     

     

     

    (9.0

    )

     

    N.M.

     

     

    (447.2

    )

     

     

    (39.4

    )

     

    N.M.

    Income tax expense (benefit), net

     

    12.5

     

     

     

    (7.6

    )

     

    N.M.

     

     

    (12.2

    )

     

     

    (10.0

    )

     

    22.0

    %

    Net loss

    $

    (9.5

    )

     

    $

    (1.4

    )

     

    N.M.

     

    $

    (435.0

    )

     

     

    (29.4

    )

     

    N.M.

     

     

     

     

     

     

     

     

     

     

     

     

    Net loss per share:

     

     

     

     

     

     

     

     

     

     

     

    Basic

    $

    (0.18

    )

     

    $

    (0.03

    )

     

    N.M.

     

    $

    (7.98

    )

     

    $

    (0.54

    )

     

    N.M.

    Diluted

    $

    (0.18

    )

     

    $

    (0.03

    )

     

    N.M.

     

    $

    (7.98

    )

     

    $

    (0.54

    )

     

    N.M.

     

     

     

     

     

     

     

     

     

     

     

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    54,624,900

     

     

     

    54,321,800

     

     

     

     

     

    54,536,500

     

     

     

    54,294,800

     

     

     

    Diluted

     

    54,624,900

     

     

     

    54,321,800

     

     

     

     

     

    54,536,500

     

     

     

    54,294,800

     

     

     

     

    N.M. - Not Meaningful

     

    MATIV HOLDINGS, INC. AND SUBSIDIARIES

    CONSOLIDATED BALANCE SHEETS

    (in millions)

    (Unaudited)

     

     

    June 30,

    2025

     

    December 31,

    2024

    ASSETS

     

     

     

    Cash and cash equivalents

    $

    95.6

     

     

    $

    94.3

    Restricted cash

     

    10.4

     

     

     

    —

     

    Accounts receivable, net

     

    208.9

     

     

     

    162.4

     

    Inventories, net

     

    344.5

     

     

     

    355.1

     

    Income taxes receivable

     

    16.6

     

     

     

    20.6

     

    Other current assets

     

    25.4

     

     

     

    25.7

     

    Total current assets

     

    701.4

     

     

     

    658.1

     

    Property, plant and equipment, net

     

    631.6

     

     

     

    620.3

     

    Finance lease right-of-use assets

     

    16.5

     

     

     

    16.2

     

    Operating lease right-of-use assets

     

    52.9

     

     

     

    46.4

     

    Deferred income tax assets

     

    0.2

     

     

     

    8.1

     

    Goodwill

     

    57.5

     

     

     

    465.6

     

    Intangible assets, net

     

    546.6

     

     

     

    553.4

     

    Other assets

     

    70.0

     

     

     

    79.8

     

    Total assets

    $

    2,076.7

     

     

    $

    2,447.9

     

    LIABILITIES AND STOCKHOLDERS' EQUITY

     

     

     

    Current debt

    $

    2.9

     

     

    $

    2.6

     

    Finance lease liabilities

     

    1.7

     

     

     

    1.6

     

    Operating lease liabilities

     

    9.8

     

     

     

    9.5

     

    Accounts payable

     

    172.9

     

     

     

    151.7

     

    Income taxes payable

     

    5.5

     

     

     

    8.4

     

    Accrued expenses and other current liabilities

     

    102.7

     

     

     

    100.7

     

    Total current liabilities

     

    295.5

     

     

     

    274.5

     

    Long-term debt

     

    1,087.7

     

     

     

    1,086.7

     

    Finance lease liabilities, noncurrent

     

    17.0

     

     

     

    16.3

     

    Operating lease liabilities, noncurrent

     

    42.3

     

     

     

    36.4

     

    Pension and other postretirement benefits

     

    56.9

     

     

     

    54.3

     

    Deferred income tax liabilities

     

    86.0

     

     

     

    100.9

     

    Other liabilities

     

    74.7

     

     

     

    20.3

     

    Total liabilities

     

    1,660.1

     

     

     

    1,589.4

     

    Stockholders' equity:

     

     

     

    Preferred stock, $0.10 par value; 10,000,000 shares authorized; none issued or outstanding

     

    —

     

     

     

    —

     

    Common stock, $0.10 par value; 100,000,000 shares authorized; 54,648,991 and 54,335,830 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively

     

    5.5

     

     

     

    5.4

     

    Additional paid-in-capital

     

    680.7

     

     

     

    675.7

     

    Retained earnings (accumulated deficit)

     

    (282.1

    )

     

     

    164.3

     

    Accumulated other comprehensive income, net of tax

     

    12.5

     

     

     

    13.1

     

    Total stockholders' equity

     

    416.6

     

     

     

    858.5

     

    Total liabilities and stockholders' equity

    $

    2,076.7

     

     

    $

    2,447.9

     

     

    MATIV HOLDINGS, INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF CASH FLOW

    (in millions)

    (Unaudited)

     

     

    Six Months Ended June 30,

     

     

    2025

     

     

     

    2024

     

    Operating

     

     

     

    Net loss

    $

    (435.0

    )

     

    $

    (29.4

    )

    Adjustments to reconcile Net loss to Net cash provided by operations:

     

     

     

    Depreciation and amortization

     

    71.5

     

     

     

    72.7

     

    Amortization of deferred issuance costs

     

    4.1

     

     

     

    3.9

     

    Goodwill impairment

     

    411.9

     

     

     

    —

     

    Other impairments

     

    5.3

     

     

     

    7.2

     

    Deferred income tax

     

    (14.2

    )

     

     

    (20.8

    )

    Pension and other postretirement benefits

     

    (1.1

    )

     

     

    (2.9

    )

    Stock-based compensation

     

    6.2

     

     

     

    6.0

     

    Loss on sale of assets

     

    0.2

     

     

     

    —

     

    (Gain) loss on foreign currency transactions

     

    5.8

     

     

     

    (0.3

    )

    Other non-cash items

     

    0.4

     

     

     

    1.2

     

    Other operating

     

    (2.3

    )

     

     

    (0.9

    )

    Net changes in operating working capital

     

    (11.1

    )

     

     

    (3.6

    )

    Net cash provided by operations

     

    41.7

     

     

     

    33.1

     

    Investing

     

     

     

    Capital spending

     

    (22.6

    )

     

     

    (20.8

    )

    Proceeds from sale of assets

     

    1.7

     

     

     

    2.0

     

    Cash received from (paid on) settlement of cross-currency swap contracts

     

    3.4

     

     

     

    (1.7

    )

    Other investing

     

    (0.1

    )

     

     

    0.5

     

    Net cash used in investing of:

     

     

     

    Continuing operations

     

    (17.6

    )

     

     

    (20.0

    )

    Discontinued operations

     

    —

     

     

     

    (12.0

    )

    Net cash used in investing

     

    (17.6

    )

     

     

    (32.0

    )

    Financing

     

     

     

    Cash dividends paid

     

    (11.4

    )

     

     

    (10.8

    )

    Proceeds from long-term debt

     

    64.0

     

     

     

    94.0

     

    Payments on long-term debt

     

    (67.4

    )

     

     

    (65.3

    )

    Payments on financing lease obligations

     

    (1.4

    )

     

     

    (0.7

    )

    Shares withheld for employee taxes

     

    (1.3

    )

     

     

    (0.8

    )

    Net cash provided by (used in) financing

     

    (17.5

    )

     

     

    16.4

     

    Effect of exchange rate changes on Cash and cash equivalents and Restricted cash

     

    5.1

     

     

     

    (4.3

    )

    Increase in cash and cash equivalents and Restricted cash

     

    11.7

     

     

     

    13.2

     

    Cash and cash equivalents and Restricted cash at beginning of period

     

    94.3

     

     

     

    120.2

     

    Cash and cash equivalents and Restricted cash at end of period

    $

    106.0

     

     

    $

    133.4

     

     

    MATIV HOLDINGS, INC. AND SUBSIDIARIES

    BUSINESS SEGMENT REPORTING

    (in millions)

    (Unaudited)

     

    Segment Results

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

    2025

     

     

     

    2024

     

     

    % Change

     

     

    2025

     

     

     

    2024

     

     

    % Change

    Net sales

     

     

     

     

     

     

     

     

     

     

     

    FAM

    $

    204.4

     

    $

    206.4

     

    (1.0

    )%

     

    $

    392.0

     

    $

    409.1

     

    (4.2

    )%

    SAS

     

    321.0

     

     

     

    317.4

     

     

    1.1

    %

     

     

    618.2

     

     

     

    614.9

     

     

    0.5

    %

    Total Consolidated

    $

    525.4

     

     

    $

    523.8

     

     

    0.3

    %

     

    $

    1,010.2

     

     

    $

    1,024.0

     

     

    (1.3

    )%

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of products sold

     

     

     

     

     

     

     

     

     

     

     

    FAM

    $

    155.5

     

     

    $

    153.8

     

     

    1.1

    %

     

    $

    311.0

     

     

    $

    314.0

     

     

    (1.0

    )%

    SAS

     

    266.2

     

     

     

    261.1

     

     

    2.0

    %

     

     

    522.9

     

     

     

    517.1

     

     

    1.1

    %

    Consolidated

    $

    421.7

     

     

    $

    414.9

     

     

    1.6

    %

     

    $

    833.9

     

     

    $

    831.1

     

     

    0.3

    %

     

     

     

     

     

     

     

     

     

     

     

     

    Total nonmanufacturing expenses

     

     

     

     

     

     

     

     

     

     

     

    FAM

    $

    24.1

     

     

    $

    26.2

     

     

    (8.0

    )%

     

    $

    48.3

     

     

    $

    50.9

     

     

    (5.1

    )%

    SAS

     

    29.8

     

     

     

    30.5

     

     

    (2.3

    )%

     

     

    57.0

     

     

     

    59.6

     

     

    (4.4

    )%

    Total segments

     

    53.9

     

     

     

    56.7

     

     

    (4.9

    )%

     

     

    105.3

     

     

     

    110.5

     

     

    (4.7

    )%

    Unallocated

     

    25.9

     

     

     

    29.9

     

     

    (13.4

    )%

     

     

    59.5

     

     

     

    59.5

     

     

    —

    %

    Consolidated

    $

    79.8

     

     

    $

    86.6

     

     

    (7.9

    )%

     

    $

    164.8

     

     

    $

    170.0

     

     

    (3.1

    )%

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and impairment

     

     

     

     

     

     

     

     

     

     

     

    FAM

    $

    2.2

     

     

    $

    1.2

     

     

    83.3

    %

     

    $

    420.1

     

     

    $

    4.5

     

     

    N.M.

    SAS

     

    0.2

     

     

     

    10.2

     

     

    (98.0

    )%

     

     

    0.5

     

     

     

    18.3

     

     

    (97.3

    )%

    Total segments

     

    2.4

     

     

     

    11.4

     

     

    (78.9

    )%

     

     

    420.6

     

     

     

    22.8

     

     

    N.M.

    Unallocated

     

    1.4

     

     

     

    0.4

     

     

    N.M.

     

     

    1.4

     

     

     

    3.4

     

     

    (58.8

    )%

    Consolidated

    $

    3.8

     

     

    $

    11.8

     

     

    (67.8

    )%

     

    $

    422.0

     

     

    $

    26.2

     

     

    N.M.

     

    Operating profit (loss)

     

     

     

     

     

     

     

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

     

     

     

    Return on Net Sales

     

     

     

     

     

    Return on Net Sales

     

     

    2025

     

     

     

    2024

     

     

    2025

     

    2024

     

     

    2025

     

     

     

    2024

     

     

    2025

     

    2024

    FAM

    $

    22.6

     

     

    $

    25.2

     

     

    11.1

    %

     

    12.2

    %

     

    $

    (387.4

    )

     

    $

    39.8

     

     

    (98.8

    )%

     

    9.7

    %

    SAS

     

    24.8

     

     

     

    15.6

     

     

    7.7

    %

     

    4.9

    %

     

     

    37.8

     

     

     

    19.8

     

     

    6.1

    %

     

    3.2

    %

    Unallocated

     

    (27.3

    )

     

     

    (30.3

    )

     

    (5.2

    )%

     

    (5.8

    )%

     

     

    (60.9

    )

     

     

    (62.9

    )

     

    (6.0

    )%

     

    (6.1

    )%

    Total Consolidated

    $

    20.1

     

     

    $

    10.5

     

     

    3.8

    %

     

    2.0

    %

     

    $

    (410.5

    )

     

    $

    (3.3

    )

     

    (40.6

    )%

     

    (0.3

    )%

     

    Non-GAAP Adjustments to Operating Profit (Loss)

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    FAM - Amortization of intangibles and other purchase accounting adjustments

    $

    8.8

     

    $

    8.6

     

    $

    17.3

     

    $

    17.3

    FAM - Restructuring, restructuring related, and impairment expenses

     

    2.2

     

     

     

    1.2

     

     

     

    420.1

     

     

     

    4.4

     

    FAM - Organizational realignment and integration costs(2)

     

    —

     

     

     

    0.1

     

     

     

    —

     

     

     

    0.1

     

    SAS - Amortization of intangibles and other purchase accounting adjustments

     

    7.2

     

     

     

    7.0

     

     

     

    14.1

     

     

     

    14.2

     

    SAS - Restructuring, restructuring related, and impairment expenses

     

    0.2

     

     

     

    10.1

     

     

     

    0.5

     

     

     

    17.7

     

    SAS - Organizational realignment and integration costs(2)

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (0.1

    )

    Unallocated - Restructuring, restructuring related, and impairment expenses

     

    1.4

     

     

     

    0.3

     

     

     

    1.4

     

     

     

    3.4

     

    Unallocated - Organizational realignment and integration costs(2)

     

    1.9

     

     

     

    2.1

     

     

     

    11.1

     

     

     

    6.5

     

    Unallocated - Divestiture costs

     

    0.3

     

     

     

    1.7

     

     

     

    1.1

     

     

     

    3.2

     

    Unallocated - Financing fees(1)

     

    1.9

     

     

     

    2.2

     

     

     

    3.9

     

     

     

    4.6

     

    Unallocated - Amortization of cloud-based software costs

     

    0.4

     

     

     

    0.2

     

     

     

    0.6

     

     

     

    0.2

     

    Total Consolidated

    $

    24.3

     

     

    $

    33.5

     

     

    $

    470.1

     

     

    $

    71.5

     

    (1) Financing fees incurred for the Receivables Sales Agreement.

    (2) Costs associated with the organizational realignment plan ("the Plan") announced on January 24, 2024 totaled $1.9 million and $0.5 million for the three months ended June 30, 2025 and 2024, respectively, and $11.1 million and $3.0 million for the six months ended June 30, 2025 and 2024, respectively, which included advisory fees, system-related initiatives, and CEO transition costs. Integration costs totaled $1.8 million and $3.6 million for the three and six months ended June 30, 2024, respectively, which included stock-based compensation, employee compensation, and consulting fees.

     

    Adjusted Operating Profit

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

     

     

     

    Return on Net Sales

     

     

     

     

     

    Return on Net Sales

     

     

    2025

     

     

     

    2024

     

     

    2025

     

    2024

     

     

    2025

     

     

     

    2024

     

     

    2025

     

    2024

    FAM

    $

    33.6

     

     

    $

    35.1

     

     

    16.4

    %

     

    17.0

    %

     

    $

    50.0

     

     

    $

    61.6

     

     

    12.8

    %

     

    15.1

    %

    SAS

     

    32.2

     

     

     

    32.7

     

     

    10.0

    %

     

    10.3

    %

     

     

    52.4

     

     

     

    51.6

     

     

    8.5

    %

     

    8.4

    %

    Unallocated

     

    (21.4

    )

     

     

    (23.8

    )

     

    (4.1

    )%

     

    (4.5

    )%

     

     

    (42.8

    )

     

     

    (45.0

    )

     

    (4.2

    )%

     

    (4.4

    )%

    Total Consolidated

    $

    44.4

     

     

    $

    44.0

     

     

    8.5

    %

     

    8.4

    %

     

    $

    59.6

     

     

    $

    68.2

     

     

    5.9

    %

     

    6.7

    %

     

    Non-GAAP Adjustments to Adjusted Operating Profit

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    FAM - Depreciation

    $

    6.9

     

    $

    6.9

     

    $

    13.50

     

    $

    13.5

    FAM - Stock-based compensation(1)

     

    0.1

     

     

     

    0.3

     

     

     

    0.4

     

     

     

    0.4

     

    SAS - Depreciation

     

    12.7

     

     

     

    13.4

     

     

     

    25.4

     

     

     

    26.8

     

    SAS - Stock-based compensation(1)

     

    0.4

     

     

     

    0.1

     

     

     

    0.8

     

     

     

    0.1

     

    Unallocated - Depreciation

     

    0.7

     

     

     

    0.4

     

     

     

    1.3

     

     

     

    0.9

     

    Unallocated - Stock-based compensation(1)

     

    2.0

     

     

     

    1.5

     

     

     

    3.4

     

     

     

    2.5

     

    Total Consolidated

    $

    22.8

     

     

    $

    22.6

     

     

    $

    44.8

     

     

    $

    44.2

     

    (1) Stock-based compensation excludes stock-based compensation included in restructuring and organizational realignment and integration costs.

     

    Adjusted EBITDA

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

     

     

     

    Return on Net Sales

     

     

     

     

     

    Return on Net Sales

     

     

    2025

     

     

     

    2024

     

     

    2025

     

    2024

     

     

    2025

     

     

     

    2024

     

     

    2025

     

    2024

    FAM

    $

    40.6

     

     

    $

    42.3

     

     

    19.9

    %

     

    20.5

    %

     

    $

    63.9

     

     

    $

    75.5

     

     

    16.3

    %

     

    18.5

    %

    SAS

     

    45.3

     

     

     

    46.2

     

     

    14.1

    %

     

    14.6

    %

     

     

    78.6

     

     

     

    78.5

     

     

    12.7

    %

     

    12.8

    %

    Unallocated

     

    (18.7

    )

     

     

    (21.9

    )

     

    (3.6

    )%

     

    (4.2

    )%

     

     

    (38.1

    )

     

     

    (41.6

    )

     

    (3.8

    )%

     

    (4.1

    )%

    Total Consolidated

    $

    67.2

     

     

    $

    66.6

     

     

    12.8

    %

     

    12.7

    %

     

    $

    104.4

     

     

    $

    112.4

     

     

    10.3

    %

     

    11.0

    %

     

    Non-GAAP Reconciliation of Organic Net Sales Growth

     

     

     

     

     

     

     

    FAM

     

    SAS

     

    Consolidated Mativ

     

    Three Months Ended June 30,

     

     

     

     

     

     

    Mativ 2024 Net Sales

    $

    206.4

     

     

    $

    317.4

     

     

    $

    523.8

     

    Divestiture/closure adjustments

     

    —

     

     

     

    (11.7

    )

     

     

    (11.7

    )

    Mativ 2024 comparable Net Sales

    $

    206.4

     

     

    $

    305.7

     

     

    $

    512.1

     

     

     

     

     

     

     

    Mativ 2025 Net Sales

    $

    204.4

     

     

    $

    321.0

     

     

    $

    525.4

     

    Divestiture/closure adjustments

     

    —

     

     

     

    —

     

     

     

    —

     

    Mativ 2025 comparable Net Sales

    $

    204.4

     

     

    $

    321.0

     

     

    $

    525.4

     

    Organic growth

     

    (1.0

    )%

     

     

    5.0

    %

     

     

    2.6

    %

     

     

     

     

     

     

    Currency effects on 2025

    $

    3.0

     

     

    $

    4.3

     

     

    $

    7.3

     

    Mativ 2025 comparable Net Sales with Currency Adjustment

    $

    201.4

     

     

    $

    316.7

     

     

    $

    518.1

     

    Organic constant currency growth

     

    (2.4

    )%

     

     

    3.6

    %

     

     

    1.2

    %

     

     

     

     

     

     

     

    MATIV HOLDINGS, INC. AND SUBSIDIARIES

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL DATA

    (in millions, except per share amounts)

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Operating profit (loss)

    $

    20.1

     

     

    $

    10.5

     

     

    $

    (410.5

    )

     

    $

    (3.3

    )

    Plus: Restructuring, restructuring related, and impairment expenses

     

    3.8

     

     

     

    11.6

     

     

     

    10.1

     

     

     

    25.5

     

    Plus: Goodwill impairment

     

    —

     

     

     

    —

     

     

     

    411.9

     

     

     

    —

     

    Plus: Purchase accounting adjustments

     

    16.0

     

     

     

    15.6

     

     

     

    31.4

     

     

     

    31.5

     

    Plus: Organizational realignment and integration costs

     

    1.9

     

     

     

    2.2

     

     

     

    11.1

     

     

     

    6.5

     

    Plus: Divestiture costs

     

    0.3

     

     

     

    1.7

     

     

     

    1.1

     

     

     

    3.2

     

    Plus: Financing fees

     

    1.9

     

     

     

    2.2

     

     

     

    3.9

     

     

     

    4.6

     

    Plus: Amortization of cloud-based software costs

     

    0.4

     

     

     

    0.2

     

     

     

    0.6

     

     

     

    0.2

     

    Adjusted operating profit

    $

    44.4

     

     

    $

    44.0

     

     

    $

    59.6

     

     

    $

    68.2

     

     

     

     

     

     

     

     

     

    Net loss

    $

    (9.5

    )

     

    $

    (1.4

    )

     

    $

    (435.0

    )

     

    $

    (29.4

    )

    Plus: Restructuring, restructuring related, and impairment expenses

     

    5.0

     

     

     

    10.6

     

     

     

    9.7

     

     

     

    21.1

     

    Plus: Goodwill impairment

     

    —

     

     

     

    —

     

     

     

    347.2

     

     

     

    —

     

    Plus: Purchase accounting adjustments

     

    17.1

     

     

     

    12.1

     

     

     

    29.0

     

     

     

    24.3

     

    Plus: Organizational realignment and integration costs

     

    4.2

     

     

     

    1.6

     

     

     

    11.1

     

     

     

    4.9

     

    Plus: Divestiture costs

     

    0.5

     

     

     

    1.4

     

     

     

    1.1

     

     

     

    2.5

     

    Plus: Change of valuation allowance on tax attributes

     

    1.4

     

     

     

    —

     

     

     

    49.6

     

     

     

    —

     

    Plus: Tax legislative changes, net of other discrete items

     

    (0.2

    )

     

     

    (5.3

    )

     

     

    (0.2

    )

     

     

    (3.3

    )

    Adjusted income (loss)

    $

    18.5

     

     

    $

    19.0

     

     

    $

    12.5

     

     

    $

    20.1

     

     

     

     

     

     

     

     

     

    Earnings (loss) per share - diluted

    $

    (0.18

    )

     

    $

    (0.03

    )

     

    $

    (7.98

    )

     

    $

    (0.54

    )

    Plus: Restructuring, restructuring related, and impairment expenses

     

    0.09

     

     

     

    0.19

     

     

     

    0.18

     

     

     

    0.39

     

    Plus: Goodwill impairment

     

    —

     

     

     

    —

     

     

     

    6.35

     

     

     

    —

     

    Plus: Purchase accounting adjustments

     

    0.31

     

     

     

    0.22

     

     

     

    0.53

     

     

     

    0.45

     

    Plus: Organizational realignment and integration costs

     

    0.08

     

     

     

    0.03

     

     

     

    0.20

     

     

     

    0.09

     

    Plus: Divestiture costs

     

    —

     

     

     

    0.03

     

     

     

    0.01

     

     

     

    0.05

     

    Plus: Change of valuation allowance on tax attributes

     

    0.03

     

     

     

    —

     

     

     

    0.91

     

     

     

    —

     

    Plus: Tax legislative changes, net of other discrete items

     

    —

     

     

     

    (0.10

    )

     

     

    —

     

     

     

    (0.07

    )

    Adjusted Earnings (loss) per share - diluted

    $

    0.33

     

     

    $

    0.34

     

     

    $

    0.20

     

     

    $

    0.37

     

     

    MATIV HOLDINGS, INC. AND SUBSIDIARIES

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL DATA

    (in millions, except per share amounts)

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net loss

    $

    (9.5

    )

     

    $

    (1.4

    )

     

    $

    (435.0

    )

     

    $

    (29.4

    )

    Plus: Interest expense

     

    18.6

     

     

     

    18.4

     

     

     

    36.4

     

     

     

    36.7

     

    Plus: Financing fees

     

    1.9

     

     

     

    2.2

     

     

     

    3.9

     

     

     

    4.6

     

    Plus: Provision for income taxes

     

    12.5

     

     

     

    (7.6

    )

     

     

    (12.2

    )

     

     

    (10.0

    )

    Plus: Depreciation & amortization

     

    36.3

     

     

     

    36.3

     

     

     

    71.6

     

     

     

    72.7

     

    Plus: Amortization of cloud-based software costs

     

    0.4

     

     

     

    0.2

     

     

     

    0.6

     

     

     

    0.2

     

    Plus: Stock compensation expense

     

    2.5

     

     

     

    1.9

     

     

     

    4.6

     

     

     

    3.0

     

    Plus: Restructuring, restructuring related, and impairment expenses

     

    3.8

     

     

     

    11.6

     

     

     

    10.1

     

     

     

    25.5

     

    Plus: Goodwill impairment

     

    —

     

     

     

    —

     

     

     

    411.9

     

     

     

    —

     

    Plus: Organizational realignment and integration costs

     

    1.9

     

     

     

    2.2

     

     

     

    11.1

     

     

     

    6.5

     

    Plus: Divestiture costs

     

    0.3

     

     

     

    1.7

     

     

     

    1.1

     

     

     

    3.2

     

    Plus: Other income (expense), net

     

    (1.5

    )

     

     

    1.1

     

     

     

    0.3

     

     

     

    (0.6

    )

    Adjusted EBITDA

    $

    67.2

     

     

    $

    66.6

     

     

    $

    104.4

     

     

    $

    112.4

     

     

     

     

     

     

     

     

     

    Cash provided by operating activities

    $

    57.6

     

     

    $

    46.1

     

     

    $

    41.7

     

     

    $

    33.1

     

    Less: Capital spending

     

    (8.7

    )

     

     

    (8.7

    )

     

     

    (22.6

    )

     

     

    (20.8

    )

    Less: Capitalized software costs

     

    —

     

     

     

    (0.1

    )

     

     

    —

     

     

     

    (0.1

    )

    Less: Cloud-based software costs

     

    —

     

     

     

    (0.5

    )

     

     

    —

     

     

     

    (1.0

    )

    Free cash flow

    $

    48.9

     

     

    $

    36.8

     

     

    $

    19.1

     

     

    $

    11.2

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    June 30, 2025

     

    December 31, 2024

    Total debt

     

     

     

     

    $

    1,090.6

     

     

    $

    1,089.3

     

    Less: Cash

     

     

     

     

     

    95.6

     

     

     

    94.3

     

    Net debt

     

     

     

     

    $

    995.0

     

     

    $

    995.0

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250806489249/en/

    Chris Kuepper, IRC

    Director, Investor Relations

    +1-770-569-4229

    Website: http://www.mativ.com

    Get the next $MATV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MATV

    DatePrice TargetRatingAnalyst
    3/24/2025$15.50 → $10.00Hold → Buy
    Stifel
    11/21/2024$15.50Hold
    Stifel
    12/12/2022$32.00Market Outperform
    CJS Securities
    More analyst ratings

    $MATV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Ritrievi Kimberly E

    4 - Mativ Holdings, Inc. (0001000623) (Issuer)

    7/2/25 6:34:50 PM ET
    $MATV
    Paper
    Basic Materials

    Director Levi Marco was granted 18,328 shares, increasing direct ownership by 41% to 62,700 units (SEC Form 4)

    4 - Mativ Holdings, Inc. (0001000623) (Issuer)

    7/2/25 6:34:11 PM ET
    $MATV
    Paper
    Basic Materials

    Director Stipancich John K was granted 18,328 shares, increasing direct ownership by 114% to 34,441 units (SEC Form 4)

    4 - Mativ Holdings, Inc. (0001000623) (Issuer)

    7/2/25 6:33:38 PM ET
    $MATV
    Paper
    Basic Materials

    $MATV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stipancich John K bought $32,000 worth of shares (5,000 units at $6.40), increasing direct ownership by 45% to 16,113 units (SEC Form 4)

    4 - Mativ Holdings, Inc. (0001000623) (Issuer)

    6/9/25 4:02:20 PM ET
    $MATV
    Paper
    Basic Materials

    Director Levi Marco bought $57,800 worth of shares (10,000 units at $5.78), increasing direct ownership by 29% to 44,732 units (SEC Form 4)

    4 - Mativ Holdings, Inc. (0001000623) (Issuer)

    6/3/25 5:04:56 PM ET
    $MATV
    Paper
    Basic Materials

    Director Cook William M bought $29,200 worth of shares (5,000 units at $5.84), increasing direct ownership by 23% to 26,436 units (SEC Form 4)

    4 - Mativ Holdings, Inc. (0001000623) (Issuer)

    6/2/25 4:06:19 PM ET
    $MATV
    Paper
    Basic Materials

    $MATV
    SEC Filings

    View All

    SEC Form 10-Q filed by Mativ Holdings Inc.

    10-Q - Mativ Holdings, Inc. (0001000623) (Filer)

    8/7/25 5:06:58 PM ET
    $MATV
    Paper
    Basic Materials

    Mativ Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Mativ Holdings, Inc. (0001000623) (Filer)

    8/6/25 4:04:26 PM ET
    $MATV
    Paper
    Basic Materials

    SEC Form 11-K filed by Mativ Holdings Inc.

    11-K - Mativ Holdings, Inc. (0001000623) (Filer)

    6/27/25 4:50:01 PM ET
    $MATV
    Paper
    Basic Materials

    $MATV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mativ Holdings upgraded by Stifel with a new price target

    Stifel upgraded Mativ Holdings from Hold to Buy and set a new price target of $10.00 from $15.50 previously

    3/24/25 8:26:08 AM ET
    $MATV
    Paper
    Basic Materials

    Stifel initiated coverage on Mativ Holdings with a new price target

    Stifel initiated coverage of Mativ Holdings with a rating of Hold and set a new price target of $15.50

    11/21/24 9:19:49 AM ET
    $MATV
    Paper
    Basic Materials

    CJS Securities initiated coverage on Mativ Holdings with a new price target

    CJS Securities initiated coverage of Mativ Holdings with a rating of Market Outperform and set a new price target of $32.00

    12/12/22 9:04:50 AM ET
    $MATV
    Paper
    Basic Materials

    $MATV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mativ Announces Participation in Upcoming Investor Conferences

    Mativ Holdings, Inc. (NYSE:MATV) today announced its participation in the following upcoming investor conferences: 2025 Seaport Research Partners Annual Summer Investor Conference – August 20, 2025 Sidoti Fall 2025 Virtual Small Cap Conference – September 18, 2025 Thank you for your interest in Mativ. We look forward to your participation in the conferences. About Mativ Mativ Holdings, Inc. is a global leader in specialty materials, solving our customers' most complex challenges by engineering bold, innovative solutions that connect, protect and purify our world. Headquartered in Alpharetta, Georgia, we manufacture on three continents and generate sales in over 90 countries thr

    8/12/25 4:05:00 PM ET
    $MATV
    Paper
    Basic Materials

    Mativ Announces Second Quarter 2025 Results

    Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE:MATV) reported earnings results for the three months ended June 30, 2025. Adjusted measures are reconciled to GAAP at the end of this release. Financial comparisons are versus the prior year period unless stated otherwise. Figures may not sum to total due to rounding. Mativ Second Quarter 2025 Highlights Sales of $525.4 million increased 0.3% year over year, and 2.6% on an organic basis GAAP loss was $9.5 million, GAAP EPS was $(0.18) Adjusted EBITDA was $67.2 million, Adjusted income was $18.5 million, and Adjusted EPS was $0.33, (see non-GAAP reconciliations). Adjusted EBITDA was up 1% versus the prior year period, as lo

    8/6/25 4:30:00 PM ET
    $MATV
    Paper
    Basic Materials

    Mativ Announces Conference Call to Discuss Second Quarter 2025 Results

    Mativ Holdings, Inc. (NYSE:MATV) today announced it will release second quarter 2025 financial results on August 6, 2025, after the market closes. A conference call to discuss these results has been scheduled for 8:30 a.m. ET on August 7, 2025. The call can be accessed via webcast or by telephone using the information set forth below. An online replay of the call will be accessible on the Investors section of Mativ's website at ir.mativ.com shortly after the webcast is complete. What: Mativ Second Quarter 2025 Earnings Release When: Thursday, August 7, 2025, at 8:30 a.m. ET Where: https://events.q4inc.com/attendee/435241925 Dial-in: United States Toll-Free: +1-833-470-1428 Internation

    7/17/25 5:22:00 PM ET
    $MATV
    Paper
    Basic Materials

    $MATV
    Leadership Updates

    Live Leadership Updates

    View All

    Mativ Appoints Shruti Singhal as President and CEO

    Singhal, Current Mativ Director, Brings Experience Leading Business Transformations and Strong Operational Execution in the Specialty Materials Industry Mativ Holdings, Inc. (NYSE:MATV) today announced the appointment of Shruti Singhal, current member of Mativ's Board of Directors, as President and Chief Executive Officer, effective today. Mr. Singhal succeeds Julie Schertell, who has stepped down as President and Chief Executive Officer, and as a director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311297460/en/Shruti Singhal, President and Chief Executive Officer, Mativ (Photo: Business Wire) Mr. Singhal brings extensiv

    3/11/25 4:15:00 PM ET
    $MATV
    Paper
    Basic Materials

    DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

    3/7/25 6:19:00 PM ET
    $ALK
    $AMBC
    $ATI
    Air Freight/Delivery Services
    Consumer Discretionary
    Property-Casualty Insurers
    Finance

    Mativ Announces Appointment of New Chair of its Board of Directors

    Mativ Holdings, Inc. (NYSE:MATV) (the "Company" or "Mativ") today announced it has appointed Dr. Kimberly E. Ritrievi as Chair of the Board of Directors, succeeding Dr. John D. Rogers, who will continue to serve as a director of Mativ and will assume the role of Audit Committee Chair. Dr. Ritrievi has served on the Company's Board of Directors since 2018, most recently serving as Chair of the Audit Committee. She is currently President at The Ritrievi Group, LLC and has served as a director of Tetra Tech, Inc. since 2013, currently serving on the Audit Committee and chairing the Strategic Planning and Enterprise Risk Committee. "I am honored to be asked to lead a talented, committed and

    4/24/24 5:48:00 PM ET
    $MATV
    Paper
    Basic Materials

    $MATV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mativ Holdings Inc.

    SC 13G/A - Mativ Holdings, Inc. (0001000623) (Subject)

    11/8/24 10:29:30 AM ET
    $MATV
    Paper
    Basic Materials

    Amendment: SEC Form SC 13G/A filed by Mativ Holdings Inc.

    SC 13G/A - Mativ Holdings, Inc. (0001000623) (Subject)

    11/6/24 3:46:11 PM ET
    $MATV
    Paper
    Basic Materials

    SEC Form SC 13G filed by Mativ Holdings Inc.

    SC 13G - Mativ Holdings, Inc. (0001000623) (Subject)

    2/14/24 9:48:18 AM ET
    $MATV
    Paper
    Basic Materials

    $MATV
    Financials

    Live finance-specific insights

    View All

    Mativ Announces Second Quarter 2025 Results

    Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE:MATV) reported earnings results for the three months ended June 30, 2025. Adjusted measures are reconciled to GAAP at the end of this release. Financial comparisons are versus the prior year period unless stated otherwise. Figures may not sum to total due to rounding. Mativ Second Quarter 2025 Highlights Sales of $525.4 million increased 0.3% year over year, and 2.6% on an organic basis GAAP loss was $9.5 million, GAAP EPS was $(0.18) Adjusted EBITDA was $67.2 million, Adjusted income was $18.5 million, and Adjusted EPS was $0.33, (see non-GAAP reconciliations). Adjusted EBITDA was up 1% versus the prior year period, as lo

    8/6/25 4:30:00 PM ET
    $MATV
    Paper
    Basic Materials

    Mativ Announces Conference Call to Discuss Second Quarter 2025 Results

    Mativ Holdings, Inc. (NYSE:MATV) today announced it will release second quarter 2025 financial results on August 6, 2025, after the market closes. A conference call to discuss these results has been scheduled for 8:30 a.m. ET on August 7, 2025. The call can be accessed via webcast or by telephone using the information set forth below. An online replay of the call will be accessible on the Investors section of Mativ's website at ir.mativ.com shortly after the webcast is complete. What: Mativ Second Quarter 2025 Earnings Release When: Thursday, August 7, 2025, at 8:30 a.m. ET Where: https://events.q4inc.com/attendee/435241925 Dial-in: United States Toll-Free: +1-833-470-1428 Internation

    7/17/25 5:22:00 PM ET
    $MATV
    Paper
    Basic Materials

    Mativ Announces First Quarter 2025 Results

    Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE:MATV) reported earnings results for the three months ended March 31, 2025. Adjusted measures are reconciled to GAAP at the end of this release. Financial comparisons are versus the prior year period unless stated otherwise. Figures may not sum to total due to rounding. Mativ First Quarter 2025 Highlights Sales of $484.8 million decreased 3.1% year over year, and 0.2% on an organic basis GAAP loss was $425.5 million, GAAP EPS was $(7.82); Results included a non-cash goodwill impairment charge of $411.9 million ($7.57 per share) as well as $14.5 million of organizational realignment and asset impairment expenses Adjusted EBITDA w

    5/7/25 4:30:00 PM ET
    $MATV
    Paper
    Basic Materials